121 related articles for article (PubMed ID: 9537224)
21. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract][Full Text] [Related]
23. Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells.
Abdollahi A; Getts LA; Sonoda G; Miller PD; Taguchi T; Godwin AK; Testa JR; Hamilton TC
J Soc Gynecol Investig; 1999; 6(1):32-40. PubMed ID: 10065424
[TBL] [Abstract][Full Text] [Related]
24. C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
Bram EE; Ifergan I; Grimberg M; Lemke K; Skladanowski A; Assaraf YG
Biochem Pharmacol; 2007 Jun; 74(1):41-53. PubMed ID: 17481587
[TBL] [Abstract][Full Text] [Related]
25. Cloning of two novel ABC transporters mapping on human chromosome 9.
Luciani MF; Denizot F; Savary S; Mattei MG; Chimini G
Genomics; 1994 May; 21(1):150-9. PubMed ID: 8088782
[TBL] [Abstract][Full Text] [Related]
26. Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells.
Materna V; Liedert B; Thomale J; Lage H
Int J Cancer; 2005 Jun; 115(3):393-402. PubMed ID: 15688364
[TBL] [Abstract][Full Text] [Related]
27. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
Komatani H; Kotani H; Hara Y; Nakagawa R; Matsumoto M; Arakawa H; Nishimura S
Cancer Res; 2001 Apr; 61(7):2827-32. PubMed ID: 11306452
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
Bergenheim AT; Henriksson R
Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
[TBL] [Abstract][Full Text] [Related]
29. Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2).
Vulevic B; Chen Z; Boyd JT; Davis W; Walsh ES; Belinsky MG; Tew KD
Cancer Res; 2001 Apr; 61(8):3339-47. PubMed ID: 11309290
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
Kawabata S; Oka M; Shiozawa K; Tsukamoto K; Nakatomi K; Soda H; Fukuda M; Ikegami Y; Sugahara K; Yamada Y; Kamihira S; Doyle LA; Ross DD; Kohno S
Biochem Biophys Res Commun; 2001 Feb; 280(5):1216-23. PubMed ID: 11162657
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of lipophilins as determinants of tumor cell response to estramustine.
Tucker JM; Lipatova Z; Beljanski V; Townsend DM; Tew KD
J Pharmacol Exp Ther; 2005 Dec; 315(3):1158-62. PubMed ID: 16120813
[TBL] [Abstract][Full Text] [Related]
32. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
[TBL] [Abstract][Full Text] [Related]
33. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the function of P-glycoprotein by estramustine.
Yang CP; Shen HJ; Horwitz SB
J Natl Cancer Inst; 1994 May; 86(9):723-5. PubMed ID: 7908991
[No Abstract] [Full Text] [Related]
35. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression.
Sangrajrang S; Denoulet P; Laing NM; Tatoud R; Millot G; Calvo F; Tew KD; Fellous A
Biochem Pharmacol; 1998 Feb; 55(3):325-31. PubMed ID: 9484799
[TBL] [Abstract][Full Text] [Related]
36. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
[TBL] [Abstract][Full Text] [Related]
37. Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines.
Zhou DC; Ramond S; Viguie F; Faussat AM; Zittoun R; Marie JP
Int J Cancer; 1996 Jan; 65(3):365-71. PubMed ID: 8575859
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
39. [The mechanism of topotecan resistance in ovarian cancer cell line].
Jia P; Wu SB; Li F; Xu Q; Wu MF; Liao GN; Lu YP; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):139-42. PubMed ID: 15196431
[TBL] [Abstract][Full Text] [Related]
40. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
